| Jun 17 |
Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds
|
| Jun 12 |
LGVN Provides Encouraging Update and Improved Revenue
|
| Jun 12 |
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
|
| Jun 11 |
Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ as a Potential Treatment for HLHS, a Rare Pediatric Cardiac Disease
|
| Jun 11 |
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
|
| Jun 10 |
Longeveron to Present at the Emerging Growth Virtual Conference on June 12, 2024
|
| Jun 3 |
Longeveron announces launch of contract development and manufacturing business
|
| Jun 3 |
Longeveron® Announces Contract Development and Manufacturing Business and First Contract
|
| May 28 |
Longeveron® to Attend BIO International Convention 2024
|
| May 18 |
Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript
|
